You are here

Eli Lilly

One year after FDA nod, Eli Lilly's Trulicity launches first consumer campaign

Fierce Pharma Marketing

Mon, 10/19/15 - 11:07 am

Has Eli Lilly Become the Poster Child for Failure?

Motley Fool

Fri, 10/16/15 - 07:47 pm

clinical trials

Merck’s CETP inhibitor seems to have very low chances of success after Eli Lilly’s similar drug failed in its late stages

Bidness, ETC

Thu, 10/15/15 - 09:41 am

CETP inhibitors

Who's Up Next? More Pharma Companies Expected To Settle Foreign Bribery Cases

Forbes

Wed, 10/14/15 - 02:15 pm

Bristol-Myers Squibb

Teva Pharmaceutical

Merck cholesterol drug's odds dim after Lilly failure

Yahoo/Reuters

Tue, 10/13/15 - 09:48 am

Did Amgen Waste $300 Million In Buying A Flawed Heart Drug?

Forbes

Mon, 10/12/15 - 01:39 pm

CETP inhibitors

Lilly Loses Its Bloom; Amgen, Regeneron Blossom

Barron's

Mon, 10/12/15 - 11:51 am

Eli Lilly's Good Cholesterol Drug Went Bad. Here's What That Means For Pharma

Forbes

Mon, 10/12/15 - 11:45 am

Eli Lilly expands cancer tie-up in fast-growing China market

Yahoo/Reuters

Mon, 10/12/15 - 09:15 am

Innovent Biologics

Lilly Halts Cholesterol Drug, Losing a Potential Blockbuster

Bloomberg

Mon, 10/12/15 - 09:05 am

clinical trials

3 ADHD Treatment Makers to Watch

Motley Fool

Mon, 10/12/15 - 08:49 am

Lilly buys rights to intranasal diabetes treatment

Marketwatch

Sat, 10/10/15 - 09:08 am

Locemia Solutions

Why Cholesterol and Alzheimer’s Could Drive Eli Lilly Shares Much Higher

24/7 Wall St

Fri, 10/9/15 - 03:57 pm

Alzheimer's disease

An inside look at Lilly's NYC expansion & focus on cancer immunotherapy

BioPharma Dive

Fri, 10/9/15 - 10:37 am

cancer immunotherapy

Oncologists' pricing pushback mounts as docs snub costly me-too drugs

Fierce Pharma

Fri, 10/9/15 - 10:10 am

Lilly Receives FDA Breakthrough Therapy Designation for Abemaciclib - a CDK 4 and 6 Inhibitor - in Advanced Breast Cancer

Yahoo

Thu, 10/8/15 - 09:13 am

advanced breast cancer

breakthrough therapies

Payers want new guidelines, more data before easing access to diabetes' CV star Jardiance

Fierce Pharma

Mon, 10/5/15 - 05:52 pm

payer negotiation

Boehringer Ingelheim

Did Eli Lilly Just Get a Leg Up on Johnson & Johnson?

Motley Fool

Tue, 09/29/15 - 10:28 pm

Zosano loses its big Eli Lilly deal, and its stock is eviscerated

Fierce Biotech

Tue, 09/29/15 - 02:20 pm

Lilly, Incyte rheumatoid arthritis drug succeeds in late-stage study

Yahoo/Reuters

Tue, 09/29/15 - 09:14 am

rheumatoid arthritis

Pages